LBM22
Product Specifications
Target
CDK|||Apoptosis
Related Pathways
Cell Cycle/Checkpoint|||Apoptosis
Bioactivity
LBM22, a CLK2 inhibitor, exhibits an IC50 value of 3.9 nM. It possesses anti-proliferative properties by inhibiting the phosphorylation of SR proteins. Additionally, LBM22 downregulates the expression of Wnt-related proteins and anti-apoptotic proteins, making it applicable in the study of non-small cell lung cancer.
Smiles
O=C1C2=C(N=C(OC)N1C)N(C(=O)N2C)C
Molecular Formula
C28H22F2N6O2
Molecular Weight
512.51
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Anthrax LF Antibody (5F502.2) [Alexa Fluor 532]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
NB100-56592AF532 0.1 mL
Mouse Monoclonal Anthrax LF Antibody (5F502.2) [Alexa Fluor 532]
Ask
View Details ![N-[ (1R) -1-[ (Methoxymethylamino) carbonyl]-3-methylbutyl]-carbamic Acid 1, 1-Dimethylethyl Ester](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
457487-01 10 mg
N-[ (1R) -1-[ (Methoxymethylamino) carbonyl]-3-methylbutyl]-carbamic Acid 1, 1-Dimethylethyl Ester
Ask
View Details 457487-02 100 mg
N-[ (1R) -1-[ (Methoxymethylamino) carbonyl]-3-methylbutyl]-carbamic Acid 1, 1-Dimethylethyl Ester
Ask
View Details GTR15118291 1 Vial
Lentiviral human CCL21 shRNA (UAS) - Lentiviral human CCL21 shRNA (UAS) plasmid
Ask
View Details